| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 528 | 406 | +30.2% |
| EBITDA | 134 | 76.6 | +74.5% |
| EBITDA margin | 25.3% | 18.9% | +6.4 pts |
| Profit before tax | 125 | 66.3 | +87.9% |
| Net profit | 94.6 | 49.4 | +91.4% |
| EPS | ₹18.50 | ₹9.67 | +91.3% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 8,449 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 145 | 145 | 48.8 | 30.4 | 17.2 | ||
| 0.0 | 0.0 | 3.6 | 0.6 | 85.5 | ||
| 8,305 | — | — | — | — | ||
| 1,658 | 1,536 | 1,572 | 1,441 | 1,682 | ||
| — | −2.3% | +9.1% | −14.4% | — | ||
| 342 | 285 | 291 | 251 | 343 | ||
| 20.6% | 18.5% | 18.5% | 17.4% | 20.4% | ||
| 270 | 213 | 220 | 192 | 298 | ||
| 225 | 180 | 186 | 149 | 229 | ||
| 13.6% | 11.7% | 11.8% | 10.3% | 13.6% | ||
| ₹44.03 | ₹35.19 | ₹36.39 | ₹29.10 | ₹44.70 | ||
| — | −3.3% | +25.0% | −34.9% | — | ||
| — | 239 | 263 | 275 | 248 | ||
| — | −128 | −47.7 | −122 | −303 | ||
| 110 | 110 | 215 | 153 | −55.0 | ||
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 8,449.5 | |
| - Cash, Equiv & ST Investments | 17.2 | 30.4 | 48.8 | 144.7 | 144.7 | |
| + Total Debt | 85.5 | 0.6 | 3.6 | 0.0 | 0.0 | |
| Enterprise Value | — | — | — | — | 8,304.7 | |
| Revenue | 1,682.3 | 1,440.6 | 1,571.8 | 1,535.9 | 1,658.3 | |
| Growth %, YoY | — | -14.4 | +9.1 | -2.3 | — | |
| EBITDA | 343.1 | 250.7 | 291.1 | 284.6 | 341.7 | |
| Margin % | 20.40 | 17.41 | 18.52 | 18.53 | 20.60 | |
| EBIT | 298.0 | 191.8 | 219.9 | 213.0 | 270.1 | |
| Net Income | 228.7 | 148.9 | 186.1 | 180.0 | 225.2 | |
| Margin % | 13.59 | 10.33 | 11.84 | 11.72 | 13.58 | |
| EPS, Adj (current shares) | 44.70 | 29.10 | 36.39 | 35.19 | 44.03 | |
| Growth %, YoY | — | -34.9 | +25.0 | -3.3 | — | |
| Cash from Operations | 248.4 | 275.0 | 263.1 | 238.6 | — | |
| Capital Expenditures | -303.4 | -122.3 | -47.7 | -128.4 | — | |
| Free Cash Flow | -55.0 | 152.7 | 215.4 | 110.1 | 110.1 | |
Prices at the 29 October 2026 close · figures from the company's filings with NSE
Alkyl Amines Chemicals (NSE: ALKYLAMINE) had a market capitalisation of ₹8,459 crore at the 29 October 2026 close (₹1,653.80 a share), a PE ratio of 37.6 on the last four quarters' profit and a price-to-book ratio of 5.52. In FY26 its standalone net profit was ₹180 crore on revenue of ₹1,536 crore; in Q1 FY27 (April–June 2026) it was ₹94.6 crore, up 91.4% year on year. It had no borrowings on 31 March 2026. Promoters held 72.04% of the shares on 30 September 2026.
Alkyl Amines Chemicals' PE ratio is 37.6 at the 29 October 2026 close (₹1,653.80 a share): a market capitalisation of ₹8,459 crore divided by standalone net profit of ₹225 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹180 crore) it is 47.0.
Alkyl Amines Chemicals' net worth — shareholders' equity in its standalone balance sheet — was ₹1,533 crore on 31 March 2026, up 9.3% from ₹1,402 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹8,459 crore at the 29 October 2026 close.
Alkyl Amines Chemicals' book value per share was ₹299.78 on 31 March 2026: shareholders' equity of ₹1,533 crore divided by the 5.12 crore shares in issue, up 9.3% from ₹274.19 a year earlier. The share price at the 29 October 2026 close was ₹1,653.80.
Alkyl Amines Chemicals' price-to-book (PB) ratio is 5.52 at the 29 October 2026 close: a market capitalisation of ₹8,459 crore divided by shareholders' equity (book value) of ₹1,533 crore on 31 March 2026. That is a book value of ₹299.78 per share against a share price of ₹1,653.80.
In FY26, Alkyl Amines Chemicals' return on equity (ROE) was 12.3% and its return on capital employed (ROCE) was 13.2%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 13.9% and ROCE 15.2%.
Alkyl Amines Chemicals' dividend yield is 0.60% at the 29 October 2026 close: dividends of ₹10 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹1,653.80. They were ₹10 on 25 June 2026.
Alkyl Amines Chemicals' market capitalisation was ₹8,459 crore at the 29 October 2026 close: 5.12 crore shares at ₹1,653.80 each.
Yes. Alkyl Amines Chemicals had no borrowings on 31 March 2026 (standalone balance sheet), and it held ₹252 crore of cash, bank balances and current investments.
Alkyl Amines Chemicals' basic earnings per share (EPS) were ₹35.20 in FY26, against ₹36.40 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹44.03.
Alkyl Amines Chemicals' debt-to-equity ratio was 0.00 on 31 March 2026: no borrowings against total equity of ₹1,533 crore. A year earlier, on 31 March 2025, it was 0.00.
Promoters held 72.04% of Alkyl Amines Chemicals on 30 September 2026, unchanged from the previous quarter and up 0.01 percentage points from 72.03% a year earlier, according to the shareholding pattern filed with NSE.
Alkyl Amines Chemicals will announce its Q2 FY27 results (July–September 2026) on Tuesday, 3 November 2026, the date of the board meeting it has notified to the exchanges.
In 2026, Alkyl Amines Chemicals has declared one dividend: ₹10 with record date 26 June 2026 and ex-date 25 June 2026.
In FY26, Alkyl Amines Chemicals generated ₹239 crore of cash from operations and spent ₹128 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹110 crore. In FY25 it was ₹215 crore.
Alkyl Amines Chemicals' latest results are for Q1 FY27 (April–June 2026), filed on 4 August 2026: standalone net profit ₹94.6 crore, up 91.4% from ₹49.4 crore in Q1 FY26; revenue from operations ₹528 crore, up 30.2% year on year.
On 30 September 2026, Alkyl Amines Chemicals' shares were held by promoters 72.04%, foreign portfolio investors (FII/FPI) 3.46%, domestic institutions (DII) 3.26% (including mutual funds at 1.33%) and retail and other non-institutional investors 21.24%. Over the year, FII holding was up 0.03 percentage points from 3.43% and DII holding was up 0.38 percentage points from 2.88%.
In FY26 (April 2025–March 2026), Alkyl Amines Chemicals' standalone net profit was ₹180 crore, down 3.3% from ₹186 crore in FY25, on revenue from operations of ₹1,536 crore (down 2.3%). Over three years, from FY23, net profit was down 21.3%.
At the 29 October 2026 closing prices, on FY26 net profit, Alkyl Amines Chemicals' PE ratio is 47.0, the second highest of the four: Balaji Amines 36.2, Aether Industries 120.9 and Archean Chemical Industries 36.3, a peer average of 64.5. Each is the company's market capitalisation at that price divided by its FY26 net profit.
On FY26 standalone figures, against Balaji Amines, Aether Industries and Archean Chemical Industries: Alkyl Amines Chemicals' operating margin of 13.9% is the lowest of the four (Balaji Amines 15.6%, Aether Industries 25.0%, Archean Chemical Industries 17.4%; peer average 19.3%); its return on equity of 12.3% is the highest of the four (Balaji Amines 9.6%, Aether Industries 7.5%, Archean Chemical Industries 8.0%; peer average 8.4%); its revenue growth over three years of −3.0% a year is the second highest of the four (Balaji Amines −9.2% a year, Aether Industries 13.0% a year, Archean Chemical Industries −10.3% a year; peer average −2.2% a year).
In FY26, Alkyl Amines Chemicals earned net profit of ₹180 crore on revenue of ₹1,536 crore, against ₹165 crore on ₹1,292 crore for Balaji Amines. Alkyl Amines Chemicals' operating margin was 13.9% (Balaji Amines 15.6%) and its return on equity 12.3% (Balaji Amines 9.6%). At the 29 October 2026 close, Alkyl Amines Chemicals' market capitalisation was ₹8,459 crore against ₹5,990 crore for Balaji Amines, and its PE ratio on FY26 profit 47.0 against 36.2.
From Alkyl Amines Chemicals' own standalone results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Standalone figures from the company's filings with NSE; prices are NSE closing prices.